| Unknown | RESULT: Reliable, Emergent Solution Using Liprotamase Treatment Exocrine Pancreatic Insufficiency, Cystic Fibrosis | Phase 3 | 2017-04-28 |
| Completed | EASY: Extended Access to Sollpura Over Years Exocrine Pancreatic Insufficiency, Cystic Fibrosis | Phase 4 | 2016-09-01 |
| Terminated | CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Eryt Systemic Lupus Erythematosus | Phase 3 | 2016-06-01 |
| Completed | SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis Exocrine Pancreatic Insufficiency, Cystic Fibrosis | Phase 3 | 2016-06-01 |
| Withdrawn | MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in S Immune Thrombocytopenic Purpura, Idiopathic Thrombocytopenic Purpura | Phase 2 / Phase 3 | 2015-12-01 |
| Withdrawn | CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Ery Systemic Lupus Erythematosus | Phase 3 | 2015-12-01 |
| Completed | SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosi Exocrine Pancreatic Insufficiency, Cystic Fibrosis | Phase 3 | 2015-06-01 |
| Withdrawn | BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Granulomatosis With Polyangiitis, Microscopic Polyangiitis | Phase 2 | 2014-12-01 |
| Withdrawn | BRILLIANT-SC: A Study of the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy IgA Nephropathy | Phase 3 | 2014-10-01 |
| Completed | BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration IgA Nephropathy | Phase 2 / Phase 3 | 2013-06-01 |
| Completed | CHABLIS-SC1: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Ery Systemic Lupus Erythematosus | Phase 3 | 2013-02-01 |
| Terminated | A Study of Varespladib Infusion in Subjects With Sickle Cell Disease. Sickle Cell Disease, Vaso-occlusive Crisis | Phase 2 | 2012-02-01 |
| Completed | Study to Assess the Metabolism and Elimination of [14C]-Labeled Varespladib Methyl in Healthy Male Subjects Healthy Volunteers | Phase 1 | 2011-06-01 |
| Terminated | A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function Renal Impairment | Phase 1 | 2011-06-01 |
| Completed | A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321 Systemic Lupus Erythematosus | Phase 2 | 2011-04-01 |
| Completed | PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Sys Systemic Lupus Erythematosus | Phase 2 | 2010-07-01 |
| Terminated | VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronar Acute Coronary Syndrome | Phase 3 | 2010-05-01 |
| Completed | FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes Acute Coronary Syndrome | Phase 2 | 2008-07-01 |
| Terminated | Phase III ALTU-135 CP Safety Trial Exocrine Pancreatic Insufficiency | Phase 3 | 2007-12-01 |
| Completed | PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease Coronary Artery Disease | Phase 2 | 2007-09-01 |
| Completed | Open-Label Phase III Long-Term Safety Trial of Liprotamase Cystic Fibrosis, Exocrine Pancreatic Insufficiency | Phase 3 | 2007-06-01 |
| Completed | Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency Cystic Fibrosis, Exocrine Pancreatic Insufficiency | Phase 3 | 2007-05-01 |
| Completed | PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease Coronary Artery Disease (CAD) | Phase 2 | 2007-04-01 |
| Completed | IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome Sickle Cell Disease, Vaso-occlusive Crisis, Acute Chest Syndrome | Phase 2 | 2006-12-01 |
| Completed | Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency Cystic Fibrosis, Pancreatic Insufficiency | Phase 2 | 2004-06-01 |